# Peter Charles Klatsky M.D. Inc. – FDA Inspection, May 20, 2025

Source: https://www.keypedia.com/records/fda_inspections/peter-charles-klatsky-md-inc/8365d691-2da5-491d-8004-bcd910d650c9
Source feed: FDA_Inspections

> FDA inspection 1271002 of Peter Charles Klatsky M.D. Inc., May 20, 2025. Classification: No Action Indicated (NAI). 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1271002
- Company Name: Peter Charles Klatsky M.D. Inc.
- Inspection Date: 2025-05-20
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1177649 - 2022-06-22

## Related Officers

- [Investigator](https://www.keypedia.com/people/paul-m-chefor/96bea4a8-b1ee-4870-ae8b-24794c67da21)

Company: https://www.keypedia.com/companies/peter-charles-klatsky-md-inc/dcfff450-6cf5-4d73-b955-033b40929e40

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d